“What I Tell My Patients”: Making Sense of New Treatment Options in EGFR-positive NSCLC episode artwork

EPISODE · Aug 22, 2025 · 31 MIN

“What I Tell My Patients”: Making Sense of New Treatment Options in EGFR-positive NSCLC

from Lung Cancer Rx · host Oncology News Central

In this episode of LungCancerRx, Eric Singhi, MD, Aakash Desai, MD, MPH, and Fawzi F. Abu Rous, MD, welcome back Christine M. Lovly, MD, PhD, to talk about the complexities of treating advanced EGFR-positive NSCLC. Dr. Lovely shares how she talks with patients about the latest data and recent trials.

Episode metadata supplied by the publisher feed · Published Aug 22, 2025

Embed this episode

NOW PLAYING

“What I Tell My Patients”: Making Sense of New Treatment Options in EGFR-positive NSCLC

0:00 31:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Lung Cancer Rx?

This episode is 31 minutes long.

When was this Lung Cancer Rx episode published?

This episode was published on August 22, 2025.

Can I download this Lung Cancer Rx episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!